메뉴 건너뛰기




Volumn 25, Issue 1, 2012, Pages 239-246

Avidinox® for tissue targeted delivery of biotinylated cells

Author keywords

AvidinOX; Biotinylated stem cells; Tissue targeted delivery

Indexed keywords

AVIDIN; BIOTIN; ALDEHYDE; ANTIBODY; AVIDIN ANTIBODY; AVIDIN DERIVATIVE; AVIDINOX; GREEN FLUORESCENT PROTEIN; PROTEIN DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

EID: 84861472179     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500126     Document Type: Article
Times cited : (5)

References (23)
  • 2
    • 79956329655 scopus 로고    scopus 로고
    • Mesenchymal stem cells in the dental tissues: Perspectives for tissue regeneration
    • Estrela C, Alencar AH, Kitten GT, Vencio EF, Gava E. Mesenchymal stem cells in the dental tissues: perspectives for tissue regeneration. Braz Dent J 2011; 22:91-8.
    • (2011) Braz Dent J , vol.22 , pp. 91-98
    • Estrela, C.1    Alencar, A.H.2    Kitten, G.T.3    Vencio, E.F.4    Gava, E.5
  • 3
    • 77149168196 scopus 로고    scopus 로고
    • Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering
    • Hong D, Chen HX, Ge R, Li JC. Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering. Anat Rec (Hoboken) 2010; 293:531-7.
    • (2010) Anat Rec (Hoboken) , vol.293 , pp. 531-537
    • Hong, D.1    Chen, H.X.2    Ge, R.3    Li, J.C.4
  • 4
    • 79954591540 scopus 로고    scopus 로고
    • Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands
    • Shi C, Jia T, Mendez-Ferrer S, et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011; 34:590-601.
    • (2011) Immunity , vol.34 , pp. 590-601
    • Shi, C.1    Jia, T.2    Mendez-Ferrer, S.3
  • 6
  • 7
    • 79959283672 scopus 로고    scopus 로고
    • An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model
    • Jin J, Zhao Y, Tan X, Guo C, Yang Z, Miao D. An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model. PLoS One 2011; 6:e21005.
    • (2011) PLoS One , vol.6
    • Jin, J.1    Zhao, Y.2    Tan, X.3    Guo, C.4    Yang, Z.5    Miao, D.6
  • 8
    • 79952600042 scopus 로고    scopus 로고
    • The use of stem cells for the repair of cardiac tissue in ischemic heart disease
    • Brenner C, Franz WM. The use of stem cells for the repair of cardiac tissue in ischemic heart disease. Expert Rev Med Devices 2011; 8:209-25.
    • (2011) Expert Rev Med Devices , vol.8 , pp. 209-225
    • Brenner, C.1    Franz, W.M.2
  • 9
    • 33750006294 scopus 로고    scopus 로고
    • Stem cell therapy after myocardial infraction: Ready for clinical application?
    • Engelmann MG, Franz WM. Stem cell therapy after myocardial infarction: ready for clinical application? Curr Opin Mol Ther 2006; 8:396-414. (Pubitemid 44566781)
    • (2006) Current Opinion in Molecular Therapeutics , vol.8 , Issue.5 , pp. 396-414
    • Engelmann, M.G.1    Franz, W.M.2
  • 10
    • 37249067491 scopus 로고    scopus 로고
    • Adult bone marrow-derived stem cells for organ regeneration and repair
    • DOI 10.1002/dvdy.21258
    • Togel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007; 236:3321-31. (Pubitemid 350276389)
    • (2007) Developmental Dynamics , vol.236 , Issue.12 , pp. 3321-3331
    • Togel, F.1    Westenfelder, C.2
  • 11
    • 60849136593 scopus 로고    scopus 로고
    • Mesenchymal stem cell homing: The devil is in the details
    • Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009; 4:206-16.
    • (2009) Cell Stem Cell , vol.4 , pp. 206-216
    • Karp, J.M.1    Leng Teo, G.S.2
  • 14
    • 0035963463 scopus 로고    scopus 로고
    • Failure to correct murine muscular dystrophy
    • DOI 10.1038/35082631
    • Ferrari G, Stornaiuolo A, Mavilio F. Failure to correct murine muscular dystrophy. Nature 2001; 441:1014-15. (Pubitemid 32612316)
    • (2001) Nature , vol.411 , Issue.6841 , pp. 1014-1015
    • Ferrari, G.1    Stornaiuolo, A.2    Mavilio, F.3
  • 15
    • 76749115266 scopus 로고    scopus 로고
    • OXavidin for tissue targeting biotinylated therapeutics
    • doi: 10.1155/2009/921434
    • De Santis R, Albertoni C, Rosi A, et al. OXavidin for tissue targeting biotinylated therapeutics. J Biomed Biotechnol 2010; doi: 10.1155/2009/921434.
    • (2010) J Biomed Biotechnol
    • De Santis, R.1    Albertoni, C.2    Rosi, A.3
  • 16
    • 77950567387 scopus 로고    scopus 로고
    • Biochemical and biological characterization of a new HABA-assisted oxidized avidin with enhanced tissue binding properties
    • Verdoliva A, Bellofiore P, Rivieccio V, et al. Biochemical and biological characterization of a new HABA-assisted oxidized avidin with enhanced tissue binding properties. J Biol Chem 2010; 286(12):9090-9.
    • (2010) J Biol Chem , vol.286 , Issue.12 , pp. 9090-9099
    • Verdoliva, A.1    Bellofiore, P.2    Rivieccio, V.3
  • 17
    • 77951944470 scopus 로고    scopus 로고
    • AvidinOX™ for highly efficient tissue pre-targeted radionuclide therapy
    • De Santis R, Leoni B, Rosi A, et al. AvidinOX™ for highly efficient tissue pre-targeted radionuclide therapy. Cancer Biother Radiopharmaceuticals 2010; 25(2):143-8.
    • (2010) Cancer Biother Radiopharmaceuticals , vol.25 , Issue.2 , pp. 143-148
    • De Santis, R.1    Leoni, B.2    Rosi, A.3
  • 18
    • 79959310494 scopus 로고    scopus 로고
    • Chemical linkage to injected tissues is a distinctive property of oxidized avidin
    • Epub ahead of print
    • De Santis R, Anastasi AM, Pelliccia A, et al. Chemical linkage to injected tissues is a distinctive property of oxidized avidin. PLoS One 2011; 6(6):e21075 Epub ahead of print
    • (2011) PLoS One , vol.6 , Issue.6
    • De Santis, R.1    Anastasi, A.M.2    Pelliccia, A.3
  • 19
    • 77958155248 scopus 로고    scopus 로고
    • Therapeutic use of avidin is not hampered by anti-avidin antibodies in humans
    • Petronzelli F, Pelliccia A, Anastasi AM, et al. Therapeutic use of avidin is not hampered by anti-avidin antibodies in humans. Cancer Biother Radiopharm 2010; 25:563-70.
    • (2010) Cancer Biother Radiopharm , vol.25 , pp. 563-570
    • Petronzelli, F.1    Pelliccia, A.2    Anastasi, A.M.3
  • 20
    • 79959301042 scopus 로고    scopus 로고
    • Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin
    • doi:10.1111/j.1742-7843.2011.00701.x
    • Petronzelli F, Anastasi AM, Pelliccia A, et al. Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin. Basic Clin Pharmacol Toxicol 2011; doi:10.1111/j.1742- 7843.2011.00701.x.
    • (2011) Basic Clin Pharmacol Toxicol
    • Petronzelli, F.1    Anastasi, A.M.2    Pelliccia, A.3
  • 21
    • 0242374480 scopus 로고    scopus 로고
    • Why does inflammation persist: A dominant role for the stromal microenvironment?
    • Douglas MR, Morrison KE, Salmon M, Buckley CD. Why does inflammation persist: a dominant role for the stromal microenvironment? Expert Rev Mol Med 2002; 4:1-18.
    • (2002) Expert Rev Mol Med , vol.4 , pp. 1-18
    • Douglas, M.R.1    Morrison, K.E.2    Salmon, M.3    Buckley, C.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.